Women’s health diagnostics lab, 7/14

July 2014—Vermillion launched Aspira Labs, which will specialize in using a biomarker-based diagnostic algorithm to inform clinical decision-making and advance personalized treatment plans in the management of gynecologic cancers. The lab, based in Austin, Tex., will also serve as an education and resource hub for health care professionals and women facing surgery for ovarian masses that are potentially cancerous and other related gynecologic conditions.

Vermillion, 949-574-3860